Ro-41-3290

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRo-41-3290
Drug Alias NameRo-41-3290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA-A receptor; benzodiazepine site agonists
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A